ArticleGynecologic oncology reports2022

The progression-free survival ratio as outcome measure in recurrent ovarian carcinoma patients: Current and future perspectives.

Nienke van de Kruis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.